GALAUSD
Gala / United States dollar
crypto Composite

There are many posts and comments asking how to find the stocks that run before they run. Well here is your chance to learn and potentially win big.
On Monday RVMD announced results from their Pancreatic Cancer trial, and the stock surged 40% (adding about 8 Billion Dollars to its market cap in one day), and has continued to climb yesterday and today.
They shared that their drug demonstrated a median OS of 13.2 months versus 6.7 months for chemotherapy.
Great stuff and very hopeful for patients, but another oncology company I am following, DRTS, is set to share its own Pancreatic Cancer trial results in about two weeks.
The last time DRTS shared Pancreas results the stock also surged about 40% (not in one day but it went on a very nice run). The results were almost a 90% disease control rate, meaning most patients could potentially live much longer (years longer, not months).
This time DRTS isn’t just sharing the results, the company that is known for doing little to no PR, is going all out with A CRUISE and GALA DINNER in which they will provide attendees with a deeper look at their progress and vision, including availability of the CEO and company leadership.
It’s impossible to know how the stock will react, but it’s safe to assume they have some good things to say, and the two latest examples we got from RVDM and DRTS themselves have been outstanding.
So that’s how you find opportunities, and it’s up to you to DYOR and decide if you’re going to be a part of it.
And if the Pancreas data isn’t enough, DRTS also has a readout for their GBM trial results, which we found out the patients are doing great (even just being alive would be a miracle), they are completing FDA Phase 3 for cSCC, commercializing in Japan where they got approved earlier this year, have a combination trial with Keytruda with results that will blow your mind (they multiply the effectiveness of the #1 selling drug in the world worth 30B$+), have partnerships brewing and so much more!

There are many posts and comments asking how to find the stocks that run before they run. Well here is your chance to learn and potentially win big.
On Monday RVMD announced results from their Pancreatic Cancer trial, and the stock surged 40% (adding about 8 Billion Dollars to its market cap in one day), and has continued to climb yesterday and today.
They shared that their drug demonstrated a median OS of 13.2 months versus 6.7 months for chemotherapy.
Great stuff and very hopeful for patients, but another oncology company I am following, DRTS, is set to share its own Pancreatic Cancer trial results in about two weeks.
The last time DRTS shared Pancreas results the stock also surged about 40% (not in one day but it went on a very nice run). The results were almost a 90% disease control rate, meaning most patients could potentially live much longer (years longer, not months).
This time DRTS isn’t just sharing the results, the company that is known for doing little to no PR, is going all out with A CRUISE and GALA DINNER in which they will provide attendees with a deeper look at their progress and vision, including availability of the CEO and company leadership.
It’s impossible to know how the stock will react, but it’s safe to assume they have some good things to say, and the two latest examples we got from RVDM and DRTS themselves have been outstanding.
So that’s how you find opportunities, and it’s up to you to DYOR and decide if you’re going to be a part of it.
And if the Pancreas data isn’t enough, DRTS also has a readout for their GBM trial results, which we found out the patients are doing great (even just being alive would be a miracle), they are completing FDA Phase 3 for cSCC, commercializing in Japan where they got approved earlier this year, have a combination trial with Keytruda with results that will blow your mind (they multiply the effectiveness of the #1 selling drug in the world worth 30B$+), have partnerships brewing and so much more!